Allergen-specific immunotherapy (AIT) is currently the only treatment that might influence the natural course of allergic diseases such as IgE-mediated food allergy, venom allergy, allergic rhinitis, or allergic asthma [1]. This evidence concerns the gene IGHE and allergic asthma.